MIS-C Reported in US Children and Adolescents Following COVID-19 Onset
U.S. report describes MIS-C inflammatory syndrome in children after COVID-19
An observational report from the United States describes clinical signs and symptoms of multisystem inflammatory syndrome in children (MIS-C…
A U.S. health report describes cases of a serious inflammatory condition in children that appeared after they had COVID-19.
Observational data show fewer COVID-19 hospitalizations and symptoms in U.S. children versus adults
Early U.S. data suggests children with COVID-19 may have milder symptoms than adults
A preliminary observational description of pediatric COVID-19 cases in the U.S.
Early U.S. data suggests children with COVID-19 may have milder symptoms than adults, with fewer hospitalizations and less fever or cough re…
Observational study finds 16% COVID-19 vaccination coverage among pregnant people in U.S
How many pregnant people got COVID shots? Early data shows gaps
An observational study of pregnant people in eight U.S.
By May 2021, only 16% of pregnant people in the U.S. had received a COVID-19 vaccine, with coverage dropping to just 6% for Black people and…
Survey explores clinician COVID-19 vaccination practices for women of reproductive age
How do doctors talk to women about COVID vaccines? A new survey asks
A survey of U.S. clinicians who offer COVID-19 vaccines to women of reproductive age, including pregnant patients, was conducted.
A new survey asks U.S. doctors how they talk to pregnant women about COVID-19 vaccines and what guidance they offer.
Report examines influenza, Tdap, and COVID-19 vaccination coverage and hesitancy in pregnant women
How many pregnant women are getting their recommended vaccines?
An observational report from the United States describes influenza, Tdap, and COVID-19 vaccination coverage and hesitancy among pregnant wom…
A new report examines how many pregnant people are getting flu, Tdap, and COVID-19 vaccines and explores reasons behind any hesitation.
Interim Recommendation Issued for Moderna COVID-19 Vaccine in Adults
Health officials issue interim recommendation for Moderna COVID-19 vaccine in adults
An interim recommendation for the use of the Moderna COVID-19 vaccine in persons aged 18 years and older in the United States has been issue…
Health officials issued an interim recommendation for adults to receive the Moderna COVID-19 vaccine in the United States.
ACIP issues interim guidance for initial COVID-19 vaccine allocation in the United States
Health officials issue interim guidance for initial COVID-19 vaccine allocation
The Advisory Committee on Immunization Practices (ACIP) has issued interim guidance for the initial allocation of COVID-19 vaccine in the Un…
Health officials released interim guidance to help states plan the fair distribution of the first limited COVID-19 vaccine supplies to healt…
ACIP Issues Interim Recommendation for Pfizer-BioNTech COVID-19 Vaccine in Adults
What did health officials recommend for COVID-19 vaccination in late 2020?
The Advisory Committee on Immunization Practices issued an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in persons…
On December 12, 2020, medical experts gave the green light for Pfizer-BioNTech COVID-19 vaccines for people aged 16 and older.
ACIP Issues Standard Recommendation for Pfizer-BioNTech COVID-19 Vaccine in Adults
CDC panel recommends Pfizer COVID-19 vaccine for people 16 and older
The ACIP has issued a standard recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years in the United States…
An expert panel now recommends the Pfizer COVID-19 vaccine for everyone aged 16 and older in the United States.
Observational report describes COVID-19 vaccination comparison between US adults with and without disabilities
How does disability affect COVID-19 vaccination rates in the U.S.?
An observational report described a comparison of COVID-19 vaccination status, intent, and perceived access between noninstitutionalized US …
A new report shows adults with disabilities in the U.S. face different realities than others when it comes to getting their COVID-19 shots.
Advisory committee recommends resuming Janssen COVID-19 vaccination for adults, citing benefits over risks
Health officials update recommendations for Johnson & Johnson COVID-19 vaccine
A U.S. advisory committee issued updated recommendations for the Janssen COVID-19 vaccine for persons aged ≥18 years.
Health officials keep the Johnson & Johnson COVID-19 vaccine available for adults but add a warning about rare clotting risks for women aged…
ACIP issues interim recommendation for Pfizer COVID-19 vaccine in adolescents aged 12-15
Health panel issues interim recommendation for Pfizer COVID-19 vaccine in adolescents
The Advisory Committee on Immunization Practices issued an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in adolesc…
A U.S. health advisory committee recommends the Pfizer COVID-19 vaccine for adolescents aged 12-15 to help prevent the virus.